サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765260

構造的心疾患用デバイスの世界市場

Structural Heart Devices

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
構造的心疾患用デバイスの世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

構造的心疾患用デバイスの世界市場は2030年までに280億米ドルに達する見込み

2024年に152億米ドルと推定される構造的心疾患用デバイスの世界市場は、2024年から2030年にかけてCAGR 10.7%で成長し、2030年には280億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである心臓弁装置は、CAGR 11.3%を記録し、分析期間終了までに119億米ドルに達すると予測されます。外科用心臓弁セグメントの成長率は、分析期間中CAGR 10.7％と推定されます。

米国市場は42億米ドルと推定、中国はCAGR10.0％で成長予測

米国の構造的心疾患用デバイス市場は、2024年に42億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに43億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.5％と9.1％と予測されています。欧州では、ドイツがCAGR約8.3%で成長すると予測されています。

世界の構造的心疾患用デバイス市場- 主要動向と促進要因のまとめ

現代医療における構造的心疾患用デバイスの役割とは？

構造的心疾患用デバイスは、大動脈弁狭窄症、僧帽弁閉鎖不全症、心房中隔欠損症などの心臓構造疾患患者の治療に不可欠です。これらの器具には、心臓弁、閉塞器、環状形成リング、閉鎖器などがあり、心臓の損傷した部分や変形した部分の修復や置換に役立っています。経カテーテル的大動脈弁置換術（TAVR）などの低侵襲技術の使用は、開心術の必要性を減らし、回復時間の短縮と入院期間の短縮につながることで、心血管治療に革命をもたらしています。世界人口の高齢化と心血管疾患の有病率の上昇に伴い、構造的心疾患用デバイスは、外科的合併症のリスクが高い患者のニーズに対応する上で、ますます不可欠なものとなっています。

どのような技術革新が構造的心疾患用デバイスの成長を促進していますか？

技術革新は構造的心疾患用デバイス市場の最前線にあり、機器の有効性の向上、手技リスクの軽減、患者の転帰の改善に焦点を当てた革新が行われています。最も重要な開発の一つは、開腹手術をせずに心臓弁の修復や交換を可能にするトランスカテーテル技術です。また、3D心エコーやMRIなどの画像技術の向上により、より正確な手技の計画と実行が可能になり、合併症が減少しています。さらに、生体適合材料の進歩が心臓弁の耐久性と性能を向上させ、スマート技術の統合がリアルタイムのモニタリングと処置後のケアを可能にしています。

構造的心疾患用デバイスの採用をリードしている市場セグメンテーションは？

デバイスの種類には、心臓弁、閉鎖器具、オクルーダー、環状形成リングなどがあり、心臓弁、特に経カテーテル心臓弁は、心臓弁膜症の治療に広く使用されているため、市場を独占しています。経カテーテル大動脈弁置換術（TAVR）や経カテーテル僧帽弁修復術（TMVR）などの手技が、低侵襲デバイスの需要を牽引しています。エンドユーザーには、病院、外来手術センター、専門クリニックが含まれ、病院は高度な医療技術を利用できるため、最大の導入者となっています。北米と欧州が構造的心疾患用デバイスの最大市場であるが、アジア太平洋は医療インフラの改善と心血管治療に対する意識の高まりにより急速に台頭しています。

構造的心疾患用デバイス市場の成長の原動力は？

構造的心疾患用デバイス市場の成長は、心血管疾患の有病率の上昇、低侵襲手技の採用増加、トランスカテーテル技術の進歩など、いくつかの要因によってもたらされます。特に先進地域における世界人口の高齢化は、心臓弁置換術やその他の心臓構造インターベンションの需要を促進しています。画像処理と生体適合性材料における技術革新がこれらの機器の安全性と有効性を高め、採用率の上昇につながっています。さらに、ヘルスケア支出の増加や、高度な心臓治療へのアクセスを改善するための政府の取り組みが、特に新興市場での市場成長を後押ししています。

セグメント

製品（心臓弁装置,外科用心臓弁,経カテーテル心臓弁,オクルーダー＆デリバリーシステム,その他製品）

調査対象企業の例

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Micro Interventional Devices, Inc.
  • TTK Healthcare Ltd.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP15047

Global Structural Heart Devices Market to Reach US$28.0 Billion by 2030

The global market for Structural Heart Devices estimated at US$15.2 Billion in the year 2024, is expected to reach US$28.0 Billion by 2030, growing at a CAGR of 10.7% over the analysis period 2024-2030. Heart Valve Devices, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$11.9 Billion by the end of the analysis period. Growth in the Surgical Heart Valves segment is estimated at 10.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 10.0% CAGR

The Structural Heart Devices market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.5% and 9.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Structural Heart Devices Market - Key Trends and Drivers Summarized

What Role Do Structural Heart Devices Play in Modern Medicine?

Structural heart devices are critical in treating patients with structural heart diseases, including conditions such as aortic stenosis, mitral regurgitation, and atrial septal defects. These devices include heart valves, occluders, annuloplasty rings, and closure devices, which help repair or replace damaged or malformed parts of the heart. The use of minimally invasive technologies, such as transcatheter aortic valve replacement (TAVR), has revolutionized cardiovascular care by reducing the need for open-heart surgery, leading to faster recovery times and reduced hospital stays. As the global population ages and the prevalence of cardiovascular diseases rises, structural heart devices are becoming increasingly essential in addressing the needs of patients who are at higher risk of surgical complications.

What Technological Innovations Are Driving Growth in Structural Heart Devices?

Technological advancements are at the forefront of the structural heart devices market, with innovations focusing on improving device efficacy, reducing procedural risks, and enhancing patient outcomes. One of the most significant developments is in transcatheter technologies, which allow for the repair or replacement of heart valves without open surgery. Improvements in imaging technologies, such as 3D echocardiography and MRI, are also enabling more precise planning and execution of procedures, reducing complications. Additionally, advancements in biocompatible materials are enhancing the durability and performance of heart valves, while the integration of smart technologies is enabling real-time monitoring and post-procedure care.

Which Market Segments Are Leading the Adoption of Structural Heart Devices?

Device types include heart valves, closure devices, occluders, and annuloplasty rings, with heart valves, particularly transcatheter heart valves, dominating the market due to their widespread use in treating valvular heart diseases. Procedures such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) are driving demand for minimally invasive devices. End-users include hospitals, ambulatory surgical centers, and specialty clinics, with hospitals being the largest adopters due to their access to advanced medical technologies. North America and Europe are the largest markets for structural heart devices, while Asia-Pacific is rapidly emerging due to improving healthcare infrastructure and increasing awareness of cardiovascular care.

What Is Driving the Growth of the Structural Heart Devices Market?

The growth in the structural heart devices market is driven by several factors, including the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and advancements in transcatheter technologies. The aging global population, particularly in developed regions, is driving the demand for heart valve replacements and other structural heart interventions. Technological innovations in imaging and biocompatible materials are enhancing the safety and efficacy of these devices, leading to higher adoption rates. Additionally, increasing healthcare expenditure and government initiatives to improve access to advanced cardiac care are fueling market growth, particularly in emerging markets.

SCOPE OF STUDY:

The report analyzes the Structural Heart Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems, Other Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Micro Interventional Devices, Inc.
  • TTK Healthcare Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Structural Heart Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Cardiovascular Diseases Drives Demand for Structural Heart Devices
    • Technological Advancements in Minimally Invasive Heart Valve Repair Propels Market Growth
    • Rising Adoption of Transcatheter Aortic Valve Replacement (TAVR) Expands Addressable Market Opportunity
    • Increasing Geriatric Population Strengthens Business Case for Structural Heart Devices
    • Surge in Heart Valve Replacement Procedures Accelerates Demand for Advanced Structural Heart Devices
    • Regulatory Approvals for Next-Generation Structural Heart Devices Propel Innovation in the Market
    • Growing Use of Structural Heart Devices in Treating Congenital Heart Defects Creates New Opportunities
    • Focus on Improving Patient Outcomes and Reducing Procedure Times Drives Adoption of Structural Heart Devices
    • Regulatory Changes and Increasing Healthcare Expenditure in Emerging Markets Fuel Market Growth
    • Surge in Demand for Non-Surgical and Minimally Invasive Treatment Options Spurs Adoption
    • Growing Awareness of Structural Heart Diseases and Diagnostic Tools Strengthens Market Penetration
    • Increasing Use of Structural Heart Devices in Hybrid Operating Rooms Expands Global Market Reach
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Structural Heart Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Structural Heart Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Heart Valve Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Heart Valve Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Surgical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Surgical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Occluders & Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Occluders & Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 17: Canada 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • JAPAN
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 18: Japan Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Japan 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • CHINA
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • EUROPE
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 22: Europe Recent Past, Current & Future Analysis for Structural Heart Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: Europe 6-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 24: Europe Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Europe 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • FRANCE
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 26: France Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: France 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • GERMANY
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 28: Germany Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Germany 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • ITALY
    • TABLE 30: Italy Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Italy 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • UNITED KINGDOM
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 32: UK Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: UK 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 34: Rest of Europe Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Rest of Europe 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Structural Heart Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 36: Asia-Pacific Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Asia-Pacific 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 38: Rest of World Recent Past, Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Rest of World 6-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders & Delivery Systems and Other Products for the Years 2025 & 2030

IV. COMPETITION